Arizona Tribune - Hypha Laboratories Applauds Call for Regulatory Changes for Functional Mushrooms

LAS VEGAS, NV / ACCESS Newswire / January 27, 2025 / Hypha Labs, Inc. (OTCQB:FUNI), a pioneer in functional mushroom sciences and the creator of the MicroPearls™ suite of products, applauds the widespread push for regulatory changes for functional mushrooms across numerous states in the country.

A recent article capsulizes the wide array of legislative initiatives across the country looking to advance functional mushroom ingredients for the benefit of those suffering from conditions such as Post-Traumatic Stress Disorder (PTSD) where mushroom ingredients have shown indications of efficacy, especially for the vast population of American veterans suffering from the condition.

From the article, "As cannabis reform spreads across the country, (some mushrooms) are seen as the next frontier. Several communities have decriminalized (certain) compounds as studies continue to show their potential benefits."

"We are most pleased to see these potential changes ahead for functional mushrooms," stated Stone Douglass, CEO, Hypha Labs. "It is in our estimation long overdue and mirrors in many ways the sea change of events that saw to the legalization of cannabis and cannabis products, creating in many ways a revolution of self-care for millions of Americans who wanted a natural way to feel better."

"The popularity of functional mushrooms of all varieties is well-established, and in our opinion, poised to explode as awareness, research, and acceptance converge to allow for individuals and perhaps even Big Pharma to help individuals utilize the all-natural magic of the mushroom in significant ways. It is worth noting that these proposed changes are occurring in Red, Blue and Purple states."

"And it is not lost on us that we believe we have democratized the process of producing mushrooms of all varieties by creating an amazing device that allows for a user to produce a harvest of mushroom ingredients in a sleek appliance no bigger than a blender that sits on a countertop in the privacy of their home.

"As these legislative changes simultaneously open self-care and new markets we are well-positioned to meet the need with our revolutionary device," added Douglass.

About Hypha Labs, Inc.

The company has developed revolutionary, cutting-edge technology focused on new methods of producing the active ingredients found in a wide array of functional mushrooms using its patent-pending mushroom accelerators. The Company is positioning itself to play an important role in the burgeoning Functional Mushroom industry in addition to being a disruptive force in future and emerging mushroom opportunities. Visit us at HyphaLabs.com.

SAFE HARBOR FORWARD LOOKING STATEMENTS:

This press release may contain forward looking statements that are based on current expectations, forecasts, and assumptions that involve risks as well as uncertainties that could cause actual outcomes and results to differ materially from those anticipated or expected, including statements related to the amount and timing of expected revenues related to our financial performance, expected revenue, contracts, and future growth for upcoming quarterly and annual periods. These risks and uncertainties are further defined in filings and reports by the Company with the U.S. Securities and Exchange Commission (SEC) and on the OTC Disclosure & News Service (OTCDNS). Actual results and the timing of certain events could differ materially from those projected in or contemplated by the forward-looking statements due to a number of factors detailed from time to time in our filings with the SEC and/or OTCDNS. Among other matters, the Company may not be able to sustain growth or achieve profitability based upon many factors including but not limited to the risk that we will not be able to find and secure construction contracts and the necessary assets that will enable us to become profitable. Reference is hereby made to cautionary statements set forth in the Company's most recent SEC and/or OTCDNS filings. We have incurred and will continue to incur significant expenses in our development stage, noting that there is no assurance that we will generate enough revenues to offset those costs in both the near and long term. New lines of business in the construction industry may expose us to additional legal and regulatory costs and unknown exposure(s), the impact of which cannot be predicted at this time. Words such as "estimate," "project," "predict," "will," "would," "should," "could," "may," "might," "anticipate," "plan," "intend," "believe," "expect," "aim," "goal," "target," "objective," "likely" or similar expressions that convey the prospective nature of events or outcomes generally indicate forward-looking statements. You should not place undue reliance on these forward-looking statements, which speak only as of this press release. Unless legally required, we undertake no obligation to update, modify or withdraw any forward-looking statements, because of new information, future events or otherwise.

From time to time, the Company may post new and material information on its website or through its social media profiles at the links below:

LN: https://www.linkedin.com/company/hypha-labs-inc/
FB: https://www.facebook.com/hyphalabs
IG: https://www.instagram.com/hyphalabsinc/

Twitter: https://x.com/Hypha_Labs

For more information about Hypha Labs visit HyphaLabs.com

For the Company's current Investor Presentation please visit www.HyphaLabs.com/deck

Investor and Media Relations:

Integrity MediaInc.
(888) 216-3595
[email protected]

View the original press release on ACCESS Newswire

Th.Gonzalez--AT